Reichel F, Auel T, Hacker MC, Seidlitz A. Rheological and physicochemical optimization of hydrogels as potential vitreous body substitutes for in vitro release testing. Eur J Pharm Sci 2025, 212: 107156, doi: 10.1016/j.ejps.2025.107156.

Schug B, Beuerle G, Bilensoy E, Cook J, Fernandes E, Haertter S, Kuribayashi R, Mehta M, Paixao P, Seidlitz A, Tampal N, Tsang YC, Walstab J, Wedemeyer R, Welink J, Jiang W. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the sixth international EUFEPS/PQRI conference. Eur J Pharm Sci 2025, 212: 107129, doi: 10.1016/j.ejps.2025.107129.

Oldfield LR, Mentrup AFC, Auel T, Seidlitz A. 3D printing of pharmaceutical dosage forms: Recent advances and applications. Adv Drug Deliv Rev 2025, 217: 115504, doi: 10.1016/j.addr.2024.115504.

Oldfield LR, Mentrup AFC, Klinken-Uth S, Auel T, Seidlitz A. From design to 3D printing: A proof-of-concept study for multiple unit particle systems (MUPS) printed by dual extrusion fused filament fabrication. Int J Pharm: X 2024, 8: 100299, doi: 10.1016/j.ijpx.2024.100299.

Wei C, Gao Z, Knabel M, Ulbricht M, Senekowitsch S, Erfurt P, Maggi N, Zwick B, Eickner T, Matin-Mann F, Seidlitz A, Lenarz T, Scheper V. Development of a drug delivering round window niche implant for cochlear pharmacotherapy. Drug Deliv 2024, 31:2392755, doi: 10.1080/10717544.2024.2392755.

Domsta V, Boralewski T, Ulbricht M, Schick P, Krause J, Seidlitz A. Stability of Dexamethasone during Hot-Melt Extrusion of Filaments based on Eudragit^® RS, Ethyl Cellulose and Polyethylene Oxide. Int J Pharm: X 2024, 8:100263, doi: 10.1016/j.ijpx.2024.100263.

Blume H, Wedemeyer S, Seidlitz A, Beuerle G, Klein S, Bilensoy E. Open Forum Conference on the ICH M13A Bioequivalence Guideline. Eur J Pharm Sci 2024, 196: 106741, doi: 10.1016/j.ejps.2024.106741.

Krause J, Domsta V, Ulbricht M, Schick P, Seidlitz A. A case study to investigate the influence of extrusion temperature, 3D printing parameters and the use of antioxidants on the degradation of dexamethasone. J Drug Deliv Sci Technol 2024, 92:105394, doi: 10.1016/j.jddst.2024.105394.

Auel T, Schubert J, Kobiakova D, Seidlitz A. Combining 3D printing, dialysis adapters, and agarose hydrogels for dissolution testing of suspensions. Trans AMMM 2023, 5: 797, doi: 10.18416/AMMM.2023.2309797.

Domsta V, Hänsch C, Lenz S, Gao Z, Matin-Mann F, Scheper V, Lenarz T, Seidlitz A. The Influence of Shape Parameters on Unidirectional Drug Release from 3D Printed Implants and Prediction of Release from Implants with Individualized Shapes. Pharmaceutics 2023, 15: 1276, doi: 10.3390/pharmaceutics15041276.

Auel T, Scherke LP, Hadlich S, Mouchantat S, Grimm M, Weitschies W, Seidlitz A. Ex Vivo Visualization of Distribution of Intravitreal Injections in the Porcine Vitreous and Hydrogels Simulating the Vitreous. Pharmaceutics 2023, 15: 786, doi: 10.3390/pharmaceutics15030786.

Domsta V, Krause J, Weitschies W, Seidlitz A. 3D Printing of Paracetamol Suppositories: An Automated Manufacturing Technique for Individualized Therapy. Pharmaceutics 2022, 14: 2676, doi: 10.3390/pharmaceutics14122676.

Mau R, Schick P, Matin-Mann F, Gao Z, Alcacer Labrador D, John S, Repp F, Lenarz T, Weitschies W, Scheper V, Seidlitz A, Seitz H. Digital light processing and drug stability of Dexamethasone-loaded implant prototypes for medical treatment of the inner ear. Trans AMMM 2022, 4: 666, doi: 10.18416/AMMM.2022.2209666.

Matin-Mann F, Gao Z, Schwieger J, Ulbricht M, Domsta V, Senekowitsch S, Weitschies W, Seidlitz A, Doll K, Stiesch M, Lenarz T, Scheper V. Individualized, Additively Manufactured Drug-Releasing External Ear Canal Implant for Prevention of Postoperative Restenosis: Development, In Vitro Testing, and Proof of Concept in an Individual Curative Trial. Pharmaceutics 2022, 14: 1242, doi: 10.3390/pharmaceutics14061242.

Auel T, Großmann L, Schulig L, Weitschies W, Seidlitz A. The EyeFlowCell: Development of a 3D-Printed Dissolution Test Setup for Intravitreal Dosage Forms. Pharmaceutics 2021; 13: 1394, doi: 10.3390/pharmaceutics13091394.

Blume HH, Mehta M, Beuerle G, Dorantes A, Hempel G, Jiang W, Kovar A, Lee J, Potthast H, Schug B, Seidlitz A, Tampal N, Y-C Tsang, Walstab J, Welink J. The Global Bioequivalence Harmonisation Initiative (GBHI): Report of EUFEPS/AAPS fourth conference, Eur J Pharm Sci 2021; 167: 105987, doi: 10.1016/j.ejps.2021.105987.

Domsta V, Seidlitz A. 3D-Printing of Drug-Eluting Implants: An Overview of the Current Developments Described in the Literature. Molecules 2021; 26: 4066, doi: 10.3390/molecules26134066.

Krause J, Müller L, Sarwinska D, Seidlitz A, Sznitowska M, Weitschies W. 3D Printing of Mini Tablets for Pediatric Use. Pharmaceuticals 2021; 14: 143, doi: 10.3390/ph14020143.

Hermans A, Dorozynski P, Muzzio FJ, Li H, Nielsen S, Chen S, Reppas C, Klein S, Patel S, Wacker M, Thakker K, Pruessmann K, Seidlitz A, Ghosh TK, Yang Y, Willett D, Hochhaus G, Tay J, Liew CV, Heng PWS, Sun CC, Kraemer J, Marques MRC. Workshop Report: USP Workshop on Advancements in In Vitro Performance Testing of Drug Products. Diss Technol 2020; 27: 52-70, doi: 10.14227/DT270220P52.

Wentzlaff M, Senz V, Seidlitz A. Evaluation of the suitability of a fluidized bed process for the coating of drug-eluting stents. Eur J Pharm Biopharm 2019; 139: 85-92, doi: 10.1208/s12249-018-1227-5.

Pruessmann K, Wentzlaff M, Schilling R, Seidlitz A. Influence of dissolution vessel geometry and dissolution medium on in vitro dissolution behaviour of triamterene-coated model stents in different test setups. AAPS PharmSciTech 2019; 20: 27, doi: 10.1208/s12249-018-1227-5.

Wirthgen E, Otten W, Tuchscherer M, Tuchscherer A, Domanska G, Brenmoehl J, Günther J, Ohde D, Weitschies W, Seidlitz A, Scheuch E, Kanitz E. Effects of 1-Methyltryptophan on Immune Responses and the Kynurenine Pathway after Lipopolysaccharide Challenge in Pigs. Int J Mol Sci 2018; 19: 3009, doi: 10.3390/ijms19103009.

Stein S, Hadlich S, Langner S, Biesenack A, Zehm N, Kruschke S, Oelze M, Grimm M, Mahnhardt S, Weitschies W, Seidlitz A. 7.1 T MRI and T2 mapping of the human and porcine vitreous body post mortem. Eur J Pharm Biopharm 2018; 131: 82-91, doi: 10.1016/j.ejpb.2018.07.021.

Kempin W, Domsta V, Brecht I, Semmling B, Tillmann S, Weitschies W, Seidlitz A. Development of a dual extrusion printing technique for an acid- and thermo-labile drug. Eur J Pharm Sci 2018; 123: 191-198, doi: 10.1016/j.ejps.2018.07.041.
Kempin W, Domsta V, Grathoff G, Brecht I, Semmling B, Tillmann S, Weitschies W, Seidlitz A. Immediate release 3d-printed tablets produced via fused deposition modeling of a Thermo-Sensitive Drug. Pharm Res 2018; 35:124, doi: 10.1007/s11095-018-2405-6.

Stein S, Auel T, Kempin W, Bogdahn M, Weitschies W, Seidlitz A. Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (D,L-lactide-co-glycolide) or polycaprolactone. Eur J Pharm Biopharm 2018; 127: 270-278, doi: 10.1016/j.ejpb.2018.02.034.

Probst M, Schmidt M, Tietz K, Klein S, Weitschies W, Seidlitz A. In vitro dissolution testing of parenteral aqueous solutions and oily suspensions of paracetamol and prednisolone. Int J Pharm 2017; 532: 519-527, doi: 10.1016/j.ijpharm.2017.09.052.

Kempin W, Baden A, Weitschies W, Seidlitz A. Glycerol gelatin for 3D-printing of implants using a paste extrusion technique. Curr Dir Biomed Engin 2017; 3: 389-392, doi: 10.1515/cdbme-2017-0081.

Stein S, Bogdahn M, Rosenbaum C, Weitschies W, Seidlitz A. Distribution of fluorescein sodium and triamcinolone acetonide in the simulated liquefied and vitrectomized Vitreous Model with simulated eye movements. Eur J Pharm Sci 2017; 109: 233-243, doi: 10.1016/j.ejps.2017.08.018.

Probst M, Kühn JP, Modeß C, Scheuch E, Seidlitz A, Hosten N, Siegmund W, Weitschies W. Muscle injury after intramuscular administration of diclofenac: a case report supported by magnetic resonance imaging. Drug Saf – Case Rep 2017; 4: 7, doi: 10.1007/s40800-017-0049-9.

Kempin W, Franz C, Koster LC, Schneider F, Bogdahn M, Weitschies W, Seidlitz A. Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants. Eur J Pharm Biopharm 2017; 115: 84-93, doi: 10.1016/j.ejpb.2017.02.014

Stein S, Bogdahn M, Weitschies W, Seidlitz A. Influence of Siluron® insertion on model drug distribution in the simulated vitreous body. Curr Dir Biomed Engin 2016; 2: 665-668, doi: 10.1515/cdbme-2016-0145.

Probst M, Schmidt M, Weitschies W, Seidlitz A. In vitro simulation of distribution processes following intramuscular injection. Curr Dir Biomed Engin 2016; 2: 383-386, doi: 10.1515/cdbme-2016-0085.

Probst M, Kühn JP, Scheuch E, Seidlitz A, Hadlich S, Evert K, Oswald S, Siegmund W, Weitschies W. Simultaneous magnetic resonance imaging and pharmacokinetic analysis of intramuscular depots. J Control Release 2016; 227: 1-12, doi: 10.1016/j.jconrel.2016.02.029.

Wirthgen E, Kanitz E, Tuchscherer M, Tuchscherer A, Domanska G, Weitschies W, Seidlitz A, Scheuch E, Otten W. Pharmacokinetics of 1-methyl-L-tryptophan after single and repeated subcutaneous application in a porcine model. Exp Anim 2016; 65: 147-155, doi: 10.1538/expanim.15-0096.

Kempin W, Kaule S, Reske T, Grabow N, Petersen S, Nagel S, Schmitz KP, Weitschies W, Seidlitz A. In vitro evaluation of paclitaxel coatings for delivery via drug-coated balloons. Eur J Pharm Biopharm 2015; 96: 322-328, doi: 10.1016/j.ejpb.2015.08.010.

Stein S, Simroth-Loch C, Langner S, Hadlich S, Stachs O, Grabow N, Guthoff R, Weitschies W, Seidlitz A. MR imaging of model drug distribution in simulated vitreous. Curr Dir Biomed Engin 2015; 1: 236-239, doi: 10.1515/cdbme-2015-0059.
Seidlitz A, Schick W, Reske T, Senz V, Grabow N, Petersen S, Nagel S, Weitschies W. In vitro study of sirolimus release from a drug-eluting stent: Comparison of the release profiles obtained using different test setups. Eur J Pharm Biopharm 2015; 93: 328-338, doi: 10.1016/j.ejpb.2015.04.016.

Seidlitz A, Wentzlaff M, Weitschies W. Controlling drug delivery from coronary stents - are we aiming for the right targets? Ther Deliv 2015; 6 (6): 705-720, doi: 10.4155/tde.15.25.

Seidlitz A, Kempin W, Reske T, Kaule S, Grabow N, Petersen S, Harder C, Nagel S, Weitschies W. Evaluation of the influence of contact time and inflation pressure on drug transfer from drug-coated balloons. Biomed Tech 2014; 59 (S1): 391-394, doi: 10.1515/bmt-2014-4170.

Wentzlaff M, Seidlitz A, Harder C, Grabow N, Weitschies W. Coating of stents with poly-L-lactide via fluidized-bed process. Biomed Tech 2014; 59 (S1): 870-873, doi: 10.1515/bmt-2014-5011.

Seidlitz A. Dissolution testing of cardiologic drug-eluting medical devices. PharmInd 2014; 76(11): 1794-1800.

Semmling B, Nagel S, Sternberg K, Weitschies W, Seidlitz A. Impact of different tissue-simulating hydrogel compartments on in vitro release and distribution from drug-eluting stents. Eur J Pharm Biopharm 2014; 87: 570-578, doi: 10.1016/j.ejpb.2014.04.010.

Loch C, Bogdahn M, Stein S, Nagel S, Guthoff R, Weitschies W, Seidlitz A. Simulation of drug distribution in the vitreous after local drug application into intact vitreous body and in progress of posterior vitreous detachment. J Pharm Sci 2014; 103(2): 517-526, doi: 10.1002/jps.23808.

Semmling B, Nagel S, Sternberg K, Weitschies W, Seidlitz A. Long-term stable hydrogels for biorelevant dissolution testing of drug-eluting stents. J Pharm Technol Drug Res 2013; 2:19, doi: 10.7243/2050-120X-2-19.

Seidlitz A, Kotzan N, Nagel S, Reske T, Grabow N, Harder C, Petersen S, Sternberg K, Weitschies W. In vitro determination of drug transfer from drug-coated balloons. PLOS ONE 2013; 8(12): e83992, doi: 10.1371/journal.pone.0083992.

Semmling B, Nagel S, Sternberg K, Weitschies W, Seidlitz A. Development of hydrophobized alginate hydrogels for the vessel-simulating flow-through cell and their usage for biorelevant drug-eluting stent testing. AAPS PharmSciTech 2013; 14 (3): 1209-1218, doi: 10.1208/s12249-013-0011-9.

Seidlitz A, Nagel S, Semmling B, Sternberg K, Kroemer HK, Weitschies W. In Vitro Dissolution Testing of Drug-Eluting Stents. Curr Pharm Biotech 2013; 14 (1): 67-75, doi: 10.2174/1389201011314010010.

Wentzlaff M, Seidlitz A, Nagel S, Harder C, Schnittker C, Trip E, Reske T, Sternberg K, Weitschies W. Coating of collars via fluidised-bed process. Biomed Tech 2012; 57 (S1): 18-21, doi: 10.1515/bmt-2012-4167.

Sternberg K, Petersen S, Grabow N, Luderer F, Bohl A, Reske T, Siewert S, Minrath I, Seidlitz A, Weitschies W, Meyer zu Schwabedissen H, Kroemer HK, Schmitz KP. Implant-associated local drug delivery systems for different medical applications. Biomed Tech 2012; 57 (S1): 393-396, doi: 10.1515/bmt-2012-4473.

Semmling B, Seidlitz A, Trip E, Schnittker C, Reske T, Sternberg K, Weitschies W. Examination of steroid release from screw-in pacing leads. Biomed Tech 2012; 57 (S1): 272-275, doi: 10.1515/bmt-2012-4138.

Loch C, Nagel S, Guthoff R, Seidlitz A, Weitschies W. The Vitreous Model - a new in vitro test method simulating the vitreous body. Biomed Tech 2012; 57 (S1): 280-283, doi: 10.1515/bmt-2012-4106.

Seidlitz A, Nagel S, Semmling B, Petersen S, Reske T, Schmidt W, Grabow N, Sternberg K, Weitschies W. In vitro estimation of drug loss during the implantation procedure of drug-eluting stents. Biomed Tech 2012; 57 (S1): 396-399, doi: 10.1515/bmt-2012-4120.

Loch C, Zakelj S, Kristl A, Nagel S, Guthoff R, Weitschies W, Seidlitz A. Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes. Eur J Pharm Sci 2012;47 (1): 131-138, doi: 10.1016/j.ejps.2012.05.007.

Seidlitz A, Weitschies W. In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing. J Pharm Pharmacol 2012; 64: 969-985, doi: 10.1111/j.2042-7158.2011.01439.x.

Sternberg K, Gratz M, Koeck K, Mostert J, Begunk R, Loebler M, Semmling B, Seidlitz A, Hildebrandt P, Homuth G, Grabow N, Tuemmler C, Weitschies W, Schmitz KP, Kroemer HK. Magnesium used in bioabsorbable stents controls smooth muscle cell proliferation and stimulates endothelial cells in vitro. J Biomed Mater Res: B 2012; 100 (1): 41-50, doi: 10.1002/jbm.b.31918.

Seidlitz A, Nagel S, Semmling B, Grabow N, Sternberg K, Weitschies W. Biorelevant Dissolution Testing of Drug-Eluting Stents: Experiences with a Modified Flow-Through Cell Setup. Dissolution Technol 2011; 18 (4): 26-34, doi: 10.14227/DT180411P26.

Seidlitz A, Nagel S, Semmling B, Grabow N, Martin H, Senz V, Harder C, Sternberg K, Schmitz KP, Kroemer HK, Weitschies W. Examination of drug release and distribution from drug-eluting stents with a vessel-simulating flow-through cell. Eur J Pharm Biopharm 2011; 78 (1): 36-48, doi: 10.1016/j.ejpb.2010.12.021.

Neubert A, Sternberg K, Nagel S, Harder C, Schmitz KP, Kroemer HK, Weitschies W. Development of a vessel-simulating flow-through cell method for the in vitro evaluation of release and distribution from drug-eluting stents. J Control Release 2008; 130 (1): 2-8, doi: 10.1016/j.jconrel.2008.05.012.